Xerostomia (Dry Mouth Disease) Therapeutics Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
Global Xerostomia (Dry Mouth Disease)
Therapeutics Market Research and Forecast Report
2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "Xerostomia (Dry Mouth Disease)
  Therapeutics Market Global Industry Trends,
  Share, Size, Growth, Opportunity and Forecast
  2024-2032," the global xerostomia (dry mouth
  disease) therapeutics market size reached US
  739.8 Million in 2023.
• Xerostomia dry mouth disease therapeutics refer
  to a range of medical treatments and
  interventions that focus on alleviating the
  symptoms and addressing the underlying causes of
  xerostomia, which is commonly known as dry mouth
  disease. They are cost-effective, convenient to
  use, and widely available as saliva stimulating
  medications, saliva substitutes, oral lubricants,
  chewing gum and lozenges, and prescription
  toothpaste and mouthwash.
• They can help stimulate the production of saliva
  in individuals and provide relief from dry mouth
  symptoms while improving overall oral comfort.
  They prevent dental issues, such as cavities,
  tooth decay, and gum disease, and maintain oral
  health. As they are beneficial in maintaining
  oral moisture and alleviating dryness and
  discomfort, the demand for xerostomia dry mouth
  disease therapeutics is increasing across the
  globe.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/xerostomia-therapeutics
  -market/requestsample

4
Report Description

• Global Xerostomia (Dry Mouth Disease)
  Therapeutics Market Trends
• At present, the rising prevalence of xerostomia
  among the masses represents one of the key
  factors impelling the market growth. Moreover,
  the increasing development of innovative and
  patient-friendly treatment options is
  strengthening the market growth. Apart from this,
  the escalating demand for sustainable and
  eco-friendly solutions that reduce environmental
  impact, along with the rising focus on enhancing
  patient comfort and quality of life, is
  positively influencing the market. In addition,
  increasing preferences for natural and bio-based
  ingredients in xerostomia therapeutics that are
  chemical-free are contributing to the market
  growth.
• Besides this, advancements in drug delivery
  systems and formulation technologies for more
  effective and convenient dry mouth therapeutics
  are supporting the growth of the market.
  Furthermore, the rising awareness about the early
  diagnosis of xerostomia among individuals is
  providing lucrative growth opportunities to
  industry investors. In line with this, the rising
  focus on dental hygiene and preventive care among
  people is propelling the market growth.
  Additionally, the growing demand for xerostomia
  dry mouth disease therapeutics among the
  geriatric population, as they are more prone to
  dry mouth, is offering a favorable market
  outlook.
• Looking forward, IMARC Group expects the market
  to reach US 985.0 Million by 2032, exhibiting a
  growth rate (CAGR) of 3.13 during 2024-2032.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/xerostomia-therapeutics
  -market

5
Report Segmentation

• Breakup by Type
• Artificial Saliva/Saliva Substitutes
• Salivary Stimulants
•  
• Breakup by Drug Type
• OTC
• Prescription
• Breakup by Distribution Channel
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

6
Report Segmentation

• Breakup by Region
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7
Competitive Landscape with Key Players

• 3M Company
• Biotene (GSK plc)
• Parnell Pharmaceuticals Inc.
• Quest Products LLC
• Saliwell Ltd
• Sun Pharmaceutical Industries Limited
• West-Ward Pharmaceutical (Hikma Pharmaceuticals
  plc).

8
Key Questions Answered in the Report
9
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4  
   Introduction    4.1    Overview    4.2    Key
  Industry Trends5    Global Xerostomia (Dry Mouth
  Disease) Therapeutics Market    5.1    Market
  Overview    5.2    Market Performance    5.3  
   Impact of COVID-19  5.4    Market Forecast
• 6     Market Breakup by Type
• 6.1 Artificial Saliva/Saliva Substitutes
• 6.1.1 Market Trends
• 6.1.2 Market Forecast
• 6.2 Salivary Stimulants
• 6.2.1 Market Trends
• 6.2.2 Market Forecast
• 7 Market Breakup by Drug Type
• 7.1 OTC
• 7.1.1 Market Trends
• 7.1.2 Market Forecast       

10
Table of Contents

• 7.2 Prescription
• 7.2.1 Market Trends
• 7.2.2 Market Forecast
• 8 Market Breakup by Distribution Channel
• 8.1 Hospital Pharmacy
• 8.1.1 Market Trends
• 8.1.2 Market Forecast
• 8.2 Retail Pharmacy
• 8.2.1 Market Trends
• 8.2.2 Market Forecast
• 8.3 Online Pharmacy
• 8.3.1 Market Trends
• 8.3.2 Market Forecast
• 9 Market Breakup by Region
• 9.1 North America
• 9.1.1 United States
• 9.1.1.1 Market Trends
• 9.1.1.2 Market Forecast
• 9.1.2 Canada

11
Partial List of Clients
12
Partial List of Clients
13
Disclaimer

• 2024 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

14
Contact Us
Visit us at
https//www.imarcgroup.com
1-631-791-1145
sales_at_imarcgroup.com
Stay With Us